2020
DOI: 10.3389/fpubh.2020.555013
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a Novel Pathogen Using Family-Wide PCR: Initial Confirmation of COVID-19 in Thailand

Abstract: In resource-limited countries, early detection of novel pathogens is often challenging, due to financial and technical constraints. This study reports the efficacy of family-wide polymerase chain reaction (PCR) in screening, detecting, and identifying initial cases of the novel SARS-CoV-2 in Thailand. Respiratory secretions were collected from suspected individuals traveling from Wuhan, China to Thailand at the beginning of January 2020. Family-wide PCR assays yielded positive results for coronavirus in one tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
1
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Expanding this comparison to four other studies that identified earlier cases, we inferred January 7, 2020 (95% CI December 22, 2019) as the most likely first case in Thailand. This is only 1 day after a case identified in a traveller to Thailand from Wuhan on January 8, 2020 [ 15 , 16 ]. However, the most likely first case in France was inferred as January 19, 2020 (95% CI January 4, 2020), while a retrospective review of medical records identified one patient as having COVID-19 from December 27 [ 6 ].…”
Section: Discussionmentioning
confidence: 99%
“…Expanding this comparison to four other studies that identified earlier cases, we inferred January 7, 2020 (95% CI December 22, 2019) as the most likely first case in Thailand. This is only 1 day after a case identified in a traveller to Thailand from Wuhan on January 8, 2020 [ 15 , 16 ]. However, the most likely first case in France was inferred as January 19, 2020 (95% CI January 4, 2020), while a retrospective review of medical records identified one patient as having COVID-19 from December 27 [ 6 ].…”
Section: Discussionmentioning
confidence: 99%
“…Secondly, HTS demonstrates superior sensitivity and speci city, enabling the identi cation of low-concentration pathogen nucleic acids and even offering effective detection for rare pathogens [11]. Additionally, this technology can uncover novel, previously unidenti ed pathogens [12]. By comparing and analyzing unknown sequences, it provides fresh insights for disease diagnosis and etiological research.…”
Section: Discussionmentioning
confidence: 99%